Description

n-Cyclohexylpropyl Deoxynojirimycin, Hydrochloride is a high-purity, chemically modified iminosugar derivative designed for advanced research and development. This compound is valued for its potent and selective glycosidase inhibitory activity, making it a critical tool for probing carbohydrate metabolism and related biological pathways. It is primarily utilized by pharmaceutical researchers, medicinal chemists, and biochemists in the development of novel therapeutics for metabolic disorders, viral infections, and cancer.

Application

• Pharmaceutical Research & Development: As a key intermediate or active pharmaceutical ingredient (API) in the synthesis of novel glycosidase inhibitors.
• Biochemical Research: Used as a selective inhibitor to study the function of specific α-glucosidases and other carbohydrate-processing enzymes in cellular systems.
• Antiviral Agent Development: Investigated for its potential to interfere with viral glycoprotein processing, targeting viruses like HIV, hepatitis, and influenza.
• Metabolic Disorder Studies: Applied in research models for diabetes, Gaucher's disease, and lysosomal storage disorders due to its effects on glycolipid metabolism.
• Cancer Research: Explored for anti-metastatic and anti-angiogenic properties linked to the inhibition of tumor cell surface glycosylation.
• Chemical Biology Probes: Serves as a scaffold for developing activity-based probes to label and monitor glycosidase enzymes in complex biological samples.

Basic Information

Product Name	n-Cyclohexylpropyl Deoxynojirimycin, Hydrochloride
CAS No.	1221793-31-2
Molecular Formula	C15H28N2O4 • HCl
Molecular Weight	336.86 g/mol (Free base: 300.40)
Synonyms	N-Cyclohexylpropyl-DNJ HCl; 1-Deoxynojirimycin, N-(3-cyclohexylpropyl)-, hydrochloride; (2R,3R,4R,5S)-2-(Hydroxymethyl)-1-[(3-cyclohexylpropyl)amino]piperidine-3,4,5-triol hydrochloride; Cyclohexylpropyl-DNJ HCl; CHP-DNJ HCl; Iminosugar Derivative C15; Glycosidase Inhibitor 1221793-31-2
EINECS	Contact for details

Quality Control

Our n-Cyclohexylpropyl Deoxynojirimycin, Hydrochloride is manufactured under strict quality control protocols to ensure batch-to-batch consistency and high purity suitable for research applications. Each lot is accompanied by a comprehensive Certificate of Analysis (COA) detailing purity, identity, and impurity profiles. We adhere to cGMP guidelines where applicable to support our clients' preclinical and development needs.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). This product is hygroscopic (moisture-sensitive) and should be handled under anhydrous conditions to maintain stability and purity. For long-term storage, consider desiccated conditions.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Assay (HPLC)	≥ 98.0%
Water Content (KF)	≤ 1.0%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 20 ppm
Single Unknown Impurity (HPLC)	≤ 0.5%
Total Impurities (HPLC)	≤ 2.0%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.